The latest innovation in organs-on-chips is the pancreas-on-a-chip, which incorporates 3D organoid technology to enhance the chip’s performance. It was developed by scientists at the Cincinnati Children’s Hospital Medical Center to study life-threatening cystic-fibrosis-related diabetes, a common complication for cystic fibrosis (CF) patients.
The study, published in Nature Communications, finds that this in-vitro model of the human pancreas has enormous potential to elucidate the causes of CF related diabetes, while also noting the failures and limitations of previous animal research.Read more
Last week, a New York judge determined that CAARE’s lawsuit against the State University of NY College of Optometry (SUNY) can move forward by denying SUNY's motion to dismiss the case.
SUNY had tried to dispel our suit by asserting frivolous claims that had no foundation in fact or in the law. Their real goal was to block CAARE from obtaining the full details about terribly invasive and injurious experiments on cats that expose their brains, confine them in devices and put them through lengthy vision testing trials.Read more
A new study conducted by an international conglomeration of scientists has found that human-based methods are more likely to produce successful results for studying treatments for deadly viruses than experiments on mice or monkeys.
The study, led by Dr. David Pamies at University of Lausanne in Switzerland, focused on a class of viruses known as mosquito-borne flaviviruses (MBF). These viruses are responsible for lethal and devastating diseases like dengue fever and Zika virus, which can cause catastrophic deformities in newborns.
The scholarly report examined human-mimetic approaches that include innovative technologies like induced pluripotent stem cell models, brain-specific organoids, in silico mathematical modeling, and others, all without the use of animals.Read more
In a remarkable sign that support for animal research is declining, the world renowned Wellcome Sanger Institute in the UK recently announced the upcoming closure of its animal research facility.Read more
At the heart of the wave of new technologies to replace animals in research are the biotech companies utilizing modern scientific methods that are fundamentally human, and not derived from animals.
CAARE recently connected with Dr. Jo Varshney, CEO and founder of VeriSIM Life. She established her company to solve the critical bottleneck in getting life-saving therapeutics from development to patients, a problem that is largely due to poor translatability from animal tests.Read more
Amyotrophic Lateral Sclerosis (ALS) is a tragic, progressive, and fatal disease that causes nerve cells to degenerate, resulting in the gradual loss of muscle control. Increasing weakness eventually disrupts the body’s ability to move, swallow, and even breathe.Read more
Despite the use of innumerable animals in cardiac experiments, cardiotoxicity – damage to the heart – remains the key reason drugs fail in clinical trials.
A growing number of scientists and biotech firms are working to change this by developing lab-grown, miniature beating human hearts. One such company, Novoheart, is pioneering an array of next-generation human heart tissue prototypes.Read more
In November 2018, the Food and Drug Administration (FDA) released a statement claiming efforts to reduce animal testing through a study aimed at eliminating the use of dogs in certain animal drug trials.Read more
Cystic fibrosis (CF) is a debilitating genetic disease caused by a mutation that disables essential proteins, resulting in thick mucus forming in the lungs, pancreas, and other organs. For patients, this results in a lifetime difficulty breathing and digestive problems. Tragically, the condition often limits the patient to a 40- or 50-year lifespan.Read more